Featured Tickers:
Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Addus HomeCare Corporation, Progyny or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.
Read on to learn how Addus HomeCare Corporation, Progyny and Inc. compare based on key financial metrics to determine which better meets your investment needs.
About Addus HomeCare Corporation, Progyny and Inc.
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Latest Health Care Providers & Services and Addus HomeCare Corporation, Progyny, Inc. Stock News
As of July 8, 2025, Addus HomeCare Corporation had a $2.0 billion market capitalization, compared to the Health Care Providers & Services median of $995.1 million. Addus HomeCare Corporation’s stock is down 10.4% in 2025, down 0.6% in the previous five trading days and down 4.52% in the past year.
Currently, Addus HomeCare Corporation’s price-earnings ratio is 25.4. Addus HomeCare Corporation’s trailing 12-month revenue is $1.2 billion with a 6.5% net profit margin. Year-over-year quarterly sales growth most recently was 20.3%. Analysts expect adjusted earnings to reach $6.114 per share for the current fiscal year. Addus HomeCare Corporation does not currently pay a dividend.
As of July 8, 2025, Progyny, Inc. had a $2.1 billion market cap, putting it in the 58th percentile of all stocks. Progyny, Inc.’s stock is up 35.9% in 2025, up 6.3% in the previous five trading days and down 14.12% in the past year.
Currently, Progyny, Inc.’s price-earnings ratio is 42.8. Progyny, Inc.’s trailing 12-month revenue is $1.2 billion with a 4.3% net profit margin. Year-over-year quarterly sales growth most recently was 16.5%. Analysts expect adjusted earnings to reach $1.618 per share for the current fiscal year. Progyny, Inc. does not currently pay a dividend.
How We Compare Addus HomeCare Corporation, Progyny and Inc. Stock Grades
Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.
AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Addus HomeCare Corporation, Progyny and Inc.’s stock grades to see how they measure up against one another.
Learn more about A+ Investor here!
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions